Chemical Component Summary

Name(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate
Identifiers[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate
FormulaC22 H18 O11
Molecular Weight458.37
TypeNON-POLYMER
Isomeric SMILESc1c(cc(c(c1O)O)O)[C@@H]2[C@@H](Cc3c(cc(cc3O2)O)O)OC(=O)c4cc(c(c(c4)O)O)O
InChIInChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1
InChIKeyWMBWREPUVVBILR-WIYYLYMNSA-N

Chemical Details

Formal Charge0
Atom Count51
Chiral Atom Count2
Bond Count54
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB12116 
NameEpigallocatechin gallate
Groupsinvestigational
DescriptionEpigallocatechin gallate has been investigated for the treatment of Hypertension and Diabetic Nephropathy.
Synonyms
  • EGCG
  • Epigallocatechin gallate
Brand NamesAntiscar
Categories
  • Anticarcinogenic Agents
  • Antimutagenic Agents
  • Antineoplastic Agents
  • Antioxidants
  • Benzopyrans
CAS number989-51-5

Drug Targets

NameTarget SequencePharmacological ActionActions
Aryl hydrocarbon receptorMNSSSANITYASRKRRKPVQKTVKPIPAEGIKSNPSKRHRDRLNTELDRL...unknown
DNA (cytosine-5)-methyltransferase 1MPARTAPARVPTLAVPAISLPDDVRRRLKDLERDSLTEKECVKEKLNLLH...unknowninhibitor
Dihydrofolate reductase, mitochondrialMFLLLNCIVAVSQNMGIGKNGDLPRPPLRNEFRYFQRMTTTSSVEGKQNL...unknown
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
CCDC/CSDVEQTIW
PubChem65064
ChEBICHEBI:4806
ChEMBLCHEMBL297453
PharosCHEMBL297453